Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial

Saved in:
Bibliographic Details
Published in:Cancer Management and Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868938310614777858
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Management and Research
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:95426
institution FRELIP
journal_source_facet Cancer Management and Research
last_indexed 2026-06-25T03:34:24.930Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
title_alt Índices nutricionales basales como indicadores pronósticos en pacientes con carcinoma nasofaríngeo recurrente o metastásico tratados con el inhibidor de PD-L1 KL-A167: un análisis secundario del ensayo KL-A167
Indices nutritionnels de base comme indicateurs pronostiques chez les patients atteints de carcinome nasopharyngé récurrent ou métastatique traités par l'inhibiteur de PD-L1 KL-A167 : une analyse secondaire de l'essai KL-A167
Índices Nutricionais Basais como Indicadores Prognósticos em Pacientes com Carcinoma Nasofaríngeo Recorrente ou Metastático Tratados com o Inibidor de PD-L1 KL-A167: Uma Análise Secundária do Ensaio KL-A167
title_auth Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
title_es_txt Índices nutricionales basales como indicadores pronósticos en pacientes con carcinoma nasofaríngeo recurrente o metastásico tratados con el inhibidor de PD-L1 KL-A167: un análisis secundario del ensayo KL-A167
title_fr_txt Indices nutritionnels de base comme indicateurs pronostiques chez les patients atteints de carcinome nasopharyngé récurrent ou métastatique traités par l'inhibiteur de PD-L1 KL-A167 : une analyse secondaire de l'essai KL-A167
title_full Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
title_fullStr Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
title_full_unstemmed Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
title_pt_txt Índices Nutricionais Basais como Indicadores Prognósticos em Pacientes com Carcinoma Nasofaríngeo Recorrente ou Metastático Tratados com o Inibidor de PD-L1 KL-A167: Uma Análise Secundária do Ensaio KL-A167
title_short Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
title_sort baseline nutritional indices as prognostic indicators in patients with recurrent or metastatic nasopharyngeal carcinoma treated with the pd-l1 inhibitor kl-a167: a secondary analysis of the kl-a167 trial
topic Oncology
General
Oncology
url https://www.dovepress.com/baseline-nutritional-indices-as-prognostic-indicators-in-patients-with-peer-reviewed-fulltext-article-CMAR